---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-22-000132"
form_type: "8-K"
ticker: "KRMD"
cik: "0000704440"
company_name: "KORU Medical Systems, Inc."
filed_at: "2022-03-02T23:59:59+00:00"
generated_at: "2026-06-27T02:38:38.349662+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# KORU Medical Q4 revenue up 60% to $6.5M, but full-year net loss widens to $4.6M

## Summary
- Q4 net revenues $6.5M (+60% YoY); adjusted growth 27.6% excluding prior-year inventory stocking.
- Full-year net loss $4.6M ($0.10 per share) vs $1.2M loss in 2020; adjusted EBITDA ($1.8M) vs $3.7M.
- Ended 2021 with $25.3M cash; expects FY2022 revenue of $26-27M with gross margin exit run rate 60%.
- Expanded label indications with three 510(k) clearances; announced strategic plan targeting $60M revenue by 2026.

## SEC filing metadata
- accession: 0001161697-22-000132
- form_type: 8-K
- ticker: KRMD
- cik: 0000704440
- company_name: KORU Medical Systems, Inc.
- filed_at: 2022-03-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/704440/000116169722000132/0001161697-22-000132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/704440/000116169722000132/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-22-000132
- JSON: https://secwatch.observer/filing/0001161697-22-000132.json
- Plain text: https://secwatch.observer/filing/0001161697-22-000132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.